249 related articles for article (PubMed ID: 11992180)
1. A clinical evaluation of tazarotene 0.1% gel, with and without a high- or mid-high-potency corticosteroid, in patients with stable plaque psoriasis.
Green L; Sadoff W
J Cutan Med Surg; 2002; 6(2):95-102. PubMed ID: 11992180
[TBL] [Abstract][Full Text] [Related]
2. A comparison of tazarotene 0.1% gel once daily plus mometasone furoate 0.1% cream once daily versus calcipotriene 0.005% ointment twice daily in the treatment of plaque psoriasis.
Guenther LC; Poulin YP; Pariser DM
Clin Ther; 2000 Oct; 22(10):1225-38. PubMed ID: 11110233
[TBL] [Abstract][Full Text] [Related]
3. Tazarotene 0.1% gel in combination with mometasone furoate cream in plaque psoriasis: a photographic tracking study.
Poulin YP
Cutis; 1999 Jan; 63(1):41-8. PubMed ID: 9951595
[TBL] [Abstract][Full Text] [Related]
4. Tazarotene 0.1% gel plus corticosteroid cream in the treatment of plaque psoriasis.
Lebwohl MG; Breneman DL; Goffe BS; Grossman JR; Ling MR; Milbauer J; Pincus SH; Sibbald RG; Swinyer LJ; Weinstein GD; Lew-Kaya DA; Lue JC; Gibson JR; Sefton J
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 1):590-6. PubMed ID: 9777766
[TBL] [Abstract][Full Text] [Related]
5. Once-daily tazarotene gel versus twice-daily fluocinonide cream in the treatment of plaque psoriasis.
Lebwohl M; Ast E; Callen JP; Cullen SI; Hong SR; Kulp-Shorten CL; Lowe NJ; Phillips TJ; Rosen T; Wolf DI; Quell JM; Sefton J; Lue JC; Gibson JR; Chandraratna RA
J Am Acad Dermatol; 1998 May; 38(5 Pt 1):705-11. PubMed ID: 9591815
[TBL] [Abstract][Full Text] [Related]
6. Optimizing treatment with topical tazarotene.
Guenther LC
Am J Clin Dermatol; 2003; 4(3):197-202. PubMed ID: 12627995
[TBL] [Abstract][Full Text] [Related]
7. Combination of calcipotriene (Dovonex) ointment and tazarotene (Tazorac) gel versus clobetasol ointment in the treatment of plaque psoriasis: a pilot study.
Bowman PH; Maloney JE; Koo JY
J Am Acad Dermatol; 2002 Jun; 46(6):907-13. PubMed ID: 12063489
[TBL] [Abstract][Full Text] [Related]
8. An observation study evaluating the treatment of plaque psoriasis with tazarotene gels, alone and with an emollient and/or corticosteroid.
Tanghetti EA;
Cutis; 2000 Dec; 66(6 Suppl):4-11. PubMed ID: 11147088
[TBL] [Abstract][Full Text] [Related]
9. Mometasone furoate 0.1%-salicylic acid 5% ointment versus mometasone furoate 0.1% ointment in the treatment of moderate-to-severe psoriasis: a multicenter study.
Koo J; Cuffie CA; Tanner DJ; Bressinck R; Cornell RC; DeVillez RL; Edwards L; Breneman DL; Piacquadio DJ; Guzzo CA; Monroe EW
Clin Ther; 1998; 20(2):283-91. PubMed ID: 9589819
[TBL] [Abstract][Full Text] [Related]
10. Investigator-masked comparison of tazarotene gel q.d. plus mometasone furoate cream q.d. vs. mometasone furoate cream b.i.d. in the treatment of plaque psoriasis.
Koo JY; Martin D
Int J Dermatol; 2001 Mar; 40(3):210-2. PubMed ID: 11422529
[No Abstract] [Full Text] [Related]
11. Combination therapy with tazarotene plus a topical corticosteroid for the treatment of plaque psoriasis.
Gollnick H; Menter A
Br J Dermatol; 1999 Apr; 140 Suppl 54():18-23. PubMed ID: 10731130
[TBL] [Abstract][Full Text] [Related]
12. Topical tazarotene: a review of its use in the treatment of plaque psoriasis.
Dando TM; Wellington K
Am J Clin Dermatol; 2005; 6(4):255-72. PubMed ID: 16060713
[TBL] [Abstract][Full Text] [Related]
13. Tazarotene in combination with topical corticosteroids.
Lebwohl M; Poulin Y
J Am Acad Dermatol; 1998 Oct; 39(4 Pt 2):S139-43. PubMed ID: 9777792
[TBL] [Abstract][Full Text] [Related]
14. Evaluating the potential clinical benefits of switching patients with plaque psoriasis from calcipotriene to tazarotene treatment.
Coynik D
Cutis; 2000 Dec; 66(6 Suppl):19-24. PubMed ID: 11147087
[TBL] [Abstract][Full Text] [Related]
15. Strategies to optimize efficacy, duration of remission, and safety in the treatment of plaque psoriasis by using tazarotene in combination with a corticosteroid.
Lebwohl M
J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S43-6. PubMed ID: 10898829
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of calcipotriol (0.005%) ointment and tazarotene (0.05% and 0.1%) gel in the treatment of stable plaque psoriasis.
Kaur I; Dogra S; Jain R; Kumar B
Indian J Dermatol Venereol Leprol; 2008; 74(5):471-4. PubMed ID: 19052406
[TBL] [Abstract][Full Text] [Related]
17. Comparison of clinical efficacy of topical tazarotene 0.1% cream with topical clobetasol propionate 0.05% cream in chronic plaque psoriasis: a double-blind, randomized, right-left comparison study.
Angelo JS; Kar BR; Thomas J
Indian J Dermatol Venereol Leprol; 2007; 73(1):65. PubMed ID: 17319037
[TBL] [Abstract][Full Text] [Related]
18. A Phase 2, Multicenter, Double-Blind, Randomized, Vehicle Controlled Clinical Study to Assess the Safety and Efficacy of a Halobetasol/Tazarotene Fixed Combination in the Treatment of Plaque Psoriasis.
Sugarman JL; Gold LS; Lebwohl MG; Pariser DM; Alexander BJ; Pillai R
J Drugs Dermatol; 2017 Mar; 16(3):197-204. PubMed ID: 28301614
[TBL] [Abstract][Full Text] [Related]
19. Tazarotene/Betamethasone Dipropionate Cream in Patients with Plaque Psoriasis: Results of a Prospective, Multicenter, Observational Study.
He C; Jin H; Liu X; Hu F; Zhang L; Zhang S; He Y; Yang X; Chen H; Wang X; Ji C; Lv C; Miao G; Li X; Diao Q; Li L; Li X; Li Y; Wang R; Zhang L; Zhou X; Xia X; Yan M; Song J; Zhang R; Geng L; Zheng M; Lu Q; Lu T; Shi Y; Jing H; Zhang X; Shi J; Xia J; Gao Y; Wang Y
Dermatology; 2021; 237(4):603-610. PubMed ID: 33352561
[TBL] [Abstract][Full Text] [Related]
20. Diflorasone diacetate ointment 0.05% versus betamethasone dipropionate ointment 0.05% in moderate-severe plaque-type psoriasis.
Shupack JL; Jondreau L; Kenny C; Stiller MJ
Dermatology; 1993; 186(2):129-32. PubMed ID: 8428041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
